ProPhase Labs Correlations
| PRPH Stock | USD 0.42 0.05 13.51% |
The current 90-days correlation between ProPhase Labs and Enzo Biochem is 0.18 (i.e., Average diversification). The correlation of ProPhase Labs is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
ProPhase Labs Correlation With Market
Modest diversification
The correlation between ProPhase Labs and DJI is 0.29 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding ProPhase Labs and DJI in the same portfolio, assuming nothing else is changed.
Moving together with ProPhase Stock
| 0.62 | NKTR | Nektar Therapeutics | PairCorr |
| 0.7 | PFE | Pfizer Inc | PairCorr |
| 0.68 | KMDA | Kamada | PairCorr |
| 0.72 | CAT | Caterpillar | PairCorr |
| 0.72 | AXP | American Express | PairCorr |
| 0.7 | BA | Boeing | PairCorr |
| 0.67 | CSCO | Cisco Systems | PairCorr |
| 0.72 | JPM | JPMorgan Chase | PairCorr |
| 0.61 | MSFT | Microsoft | PairCorr |
| 0.76 | DD | Dupont De Nemours | PairCorr |
| 0.65 | GE | GE Aerospace Earnings Call Tomorrow | PairCorr |
| 0.61 | IBM | International Business Earnings Call This Week | PairCorr |
| 0.68 | MMM | 3M Company | PairCorr |
Moving against ProPhase Stock
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between ProPhase Stock performing well and ProPhase Labs Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze ProPhase Labs' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| LMDX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| STRR | 3.07 | 0.02 | (0.01) | 0.17 | 3.94 | 7.22 | 38.42 | |||
| ENZ | 4.58 | 0.47 | 0.04 | (3.76) | 5.76 | 12.50 | 41.50 | |||
| GTH | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| STIM | 2.19 | (0.08) | 0.00 | (0.07) | 0.00 | 5.66 | 14.01 | |||
| INBS | 3.79 | 0.87 | 0.20 | 3.50 | 3.10 | 11.48 | 21.36 | |||
| BDSX | 6.09 | (0.46) | 0.00 | (4.08) | 0.00 | 13.79 | 58.86 | |||
| PRPO | 5.21 | 1.63 | 0.31 | 3.04 | 4.52 | 15.28 | 55.08 | |||
| DRIO | 2.49 | 0.01 | (0.01) | 0.15 | 3.02 | 5.97 | 16.48 | |||
| OLK | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ProPhase Labs Corporate Management
| Billy White | Consultant | Profile | |
| Lance Bisesar | Corporate Controller | Profile | |
| Robert Morse | Principal Controller | Profile | |
| Stu Hollenshead | Chief Officer | Profile | |
| Sergio Miralles | Executive Diagnostics | Profile | |
| Kamal Obbad | Senior Genomics | Profile |